The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for ...

The oxytocin system -- which helps release breast milk and strengthens the bond between mother and baby -- may be affected during breastfeeding in mothers experiencing postnatal depression.

The oxytocin system - which helps release breast milk and strengthens the bond between mother and baby - may be affected ...

The oxytocin system – which helps release breast milk and strengthens the bond between mother and baby – may be affected ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic reactions in patients who weigh between 15 and 30 kilograms, the company said on ...

Nasal spray shows preclinical promise for treating traumatic brain injury. ScienceDaily . Retrieved March 20, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250227125519.htm ...

Breastfeeding mothers with postnatal depression show disruptions in oxytocin systems, impacting bonding and milk release.

Emergent BioSolutions will lead commercial launch efforts to increase access to intranasal naloxone and combat opioid overdose poisonings in Canada<p ...